- Home
- WMK vs SRPT Comparison
WMK vs SRPT Comparison
Compare WMK & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- SRPT
- Stock Information
- Founded
- WMK 1912
- SRPT 1980
- Country
- WMK United States
- SRPT United States
- Employees
- WMK N/A
- SRPT N/A
- Industry
- WMK Food Chains
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- SRPT Health Care
- Exchange
- WMK Nasdaq
- SRPT Nasdaq
- Market Cap
- WMK 1.8B
- SRPT 1.9B
- IPO Year
- WMK N/A
- SRPT 1997
- Fundamental
- Price
- WMK $65.92
- SRPT $23.90
- Analyst Decision
- WMK
- SRPT Hold
- Analyst Count
- WMK 0
- SRPT 30
- Target Price
- WMK N/A
- SRPT $36.56
- AVG Volume (30 Days)
- WMK 120.6K
- SRPT 5.4M
- Earning Date
- WMK 11-06-2025
- SRPT 11-03-2025
- Dividend Yield
- WMK 2.06%
- SRPT N/A
- EPS Growth
- WMK 15.99
- SRPT N/A
- EPS
- WMK 4.02
- SRPT N/A
- Revenue
- WMK $4,842,632,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- WMK N/A
- SRPT $9.68
- Revenue Next Year
- WMK N/A
- SRPT N/A
- P/E Ratio
- WMK $16.40
- SRPT N/A
- Revenue Growth
- WMK 1.75
- SRPT 64.89
- 52 Week Low
- WMK $62.25
- SRPT $10.42
- 52 Week High
- WMK $90.23
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- WMK 33.58
- SRPT 60.92
- Support Level
- WMK $65.46
- SRPT $21.29
- Resistance Level
- WMK $68.80
- SRPT $24.38
- Average True Range (ATR)
- WMK 1.48
- SRPT 1.05
- MACD
- WMK -0.25
- SRPT 0.02
- Stochastic Oscillator
- WMK 8.52
- SRPT 86.38
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.